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Technetium-99m (Tc-99m) teboroxime is a new perfusion tracer 
that is highly extracted and rapidly cleared by the myocardium. 
To determine the feasibility of Tc-99m teboroxime imaging in the 
diagnosis of patients with suspected coronary artery disease, 30 
patients underwent single photon emission computed tomography 
imaging with Tc-99m teboroxime (25.2 ± 1 mCi) at peak exercise 
and again 60 min later at rest. All patients underwent either a 
thallium stress test (n = 26) or automated quantitative coronary 
arteriography (n = 25), or both, without intervening revascular-
ization or infarction. Images were reviewed by two investigators 
who had no knowledge of clinical data. Coronary lesions with 
2::50% diameter narrowing by quantitative coronary arteriogra-
phy were considered significant. 
Both thallium and Tc-99m teboroxime detected disease in all 
Thallium imaging is a useful adjunct for the diagnosis of 
coronary artery disease. However, thallium-201 is limited as 
a tracer by a low photon energy (80 keY), which contributes 
to problems with attenuation and a long half-life (73 h) that 
precludes higher doses. Accordingly, several radiopharma-
ceuticals based on technetium-99m (Tc-99m) have been 
developed for perfusion imaging. Compared with thallium. 
Tc-99m has a shorter physical half-life (6 h) and higher 
photon energy (140 keY). which allows higher count rates to 
be obtained with use of increased doses and decreased tissue 
attenuation. 
Tc-99m teboroxime (SQ30217) is a lipophilic compound 
derived from a boronic acid adduct of technetium oxime 
(BATO). It has a myocardial extraction of >90% over a wide 
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patients with two or three vessel disease. One vessel disease was 
detected with Tc-99m teboroxime in 9 of 10 patients and with 
thallium in 8 of 10 (p = NS). In patients without angiographically 
significant disease, Tc-99m teboroxime demonstrated normal per-
fusion in six of eight patients and thallium in three of five (p = 
NS). Overall, when presence or absence of disease detected by 
Tc-99m teboroxime or thallium was compared with quantitative 
coronary arteriography, there was no difference between Tc-99m 
teboroxime and thallium. These results suggest that Tc-99m 
teboroxime is comparable to thallium as an imaging agent. The 
rapid biologic half-life, 5.3 min, allows studies to be completed in 
60 to 90 min. 
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range of coronary blood flow 0-3). After uptake, the tracer 
clears the myocardium rapidly (biologic half-life of 5.3 min) 
and then concentrates in the hepatobiliary system (4-6). 
Good cardiac images have been reported in clinical studies 
(7,8) performed with planar imaging initiated approximately 
3 min after administration of the tracer, although liver 
activity obscured the inferior wall of the heart in some 
patients. The purpose of the present study was to determine 
the feasibility of single photon emission computed tomogra-
phy (SPECT) imaging with Tc-99m teboroxime and its 
relation to the anatomic severity of the stenosis as deter-
mined by quantitative coronary arteriography. Imaging was 
started within 2 min of injection to minimize scatter from the 
liver. In addition, the results of Tc-99m teboroxime studies 
were compared with those of stress SPECT thallium imag-
mg. 
Methods 
Study patients. Thirty subjects suspected of having cor-
onary artery disease and undergoing either a thallium stress 
test or coronary arteriography, or both. were enrolled in the 
0735-1097/91/$3.50 
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Table 1. Clinical Characteristics of 30 Patients 
Pt. No. Age (yr)/Gender MI Collat EF ('70) PTCA 
52/M Sub + 56 
2 45/M + 50 
3 42/M Sept 43 LAD 
4 62/F 65 
5 65/M Sub + 50 
6 72/F 60 
7 55/M lnf 81 LAD 
8 57/M 55 
9 551F 60 
10 64/M LBBB + NA 
11 57/M + 63 
12 44/F Sub NA RCA 
13 44/F Ant 68 
14 69/F Inf 70 RCA 
15 57/M Sept + 65 
16 62/M Inf + 60 
17 30/F NA 60 
18 65/M 60 
19 60/M NA NA 
20 841M + 64 
21 65/M Inf 60 
22 64/F 65 
23 451F 65 
24 59/F NA NA 
25 411F NA NA 
26 56/M NA NA 
27 451F NA 
28 53/M lnfl 40 
Sept 
29 371M Lat 62 LAD 
30 53/M Sub + 74 
Mean 55.3 232 60.7 
±SD 11.3 54 9.2 
Ant = anterior; Coli at = collateral vessels; % EF = ejection fraction by 
contrast ventriculography; F = female; Inf = inferior; Lat = lateral; LAD = 
left anterior descending coronary artery; LBBB = left bundle branch block; M 
= male; MI = myocardial infarction; NA = not available; Pt. = patient; 
PTCA = percutaneous transluminal coronary angioplasty; RCA = right 
coronary artery; Sept = septal; Sub = subendocardial; - = none (MI, CollaO 
or not performed (PTCA); + = present. 
study from July 1989 to March 1990. Patients who had a 
history of cardiomyopathy, severe valvular disease, unstable 
angina, pregnancy or morbid obesity or who had a myocar-
dial infarction, angioplasty or bypass surgery between stud-
ies were excluded. All patients signed a consent form 
approved by the University of Texas-Houston Institutional 
Review Board for the Protection of Human Subjects. There 
were 18 men and 12 women (mean age 55.3 years) (Table I). 
All 30 patients underwent Tc-99m teboroxime SPECT imag-
ing, 26 thallium SPECT imaging, 25 coronary arteriography 
and 21 all three studies. In patients who had prior angio-
plasty, perfusion scans were compared with the postangio-
plasty arteriogram. 
Each study was performed in the fasted state. There was 
an average of 16 ± 28 days between nuclear studies and all 
three studies were completed within a mean of21 ± 31 days. 
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Complete blood chemistry determinations, blood count and 
urinalysis were performed before and within 24 h of the 
Tc-99m teboroxime injection. There were no significant 
abnormalities in any of these values after Tc-99m teborox-
ime imaging. 
Coronary arteriography. Coronary arteriography was 
performed with the Judkins technique. Multiple simulta-
neous biplane views were obtained after contrast injection 
with standard doses of either Hypaque or Isovue (3 to 10 mI). 
Filming was performed at 30 frames/so The resolution of the 
cine system was 4 to 5 line pairs/mm, with both pincushion 
and magnification correction carried out in the quantitative 
coronary arteriographic analysis according to the methods of 
Brown et al. (9). Selected end-diastolic cine frames were 
digitized by a Spatial Data System frame grabber (640 x 480 
matrix) with optical magnification so as to obtain a spatial 
resolution of approximately 0.1 mm/pixel. Subsequent image 
processing (border recognition, magnification correction and 
determinations of stenosis morphology were performed with 
previously validated software (10-12) running on a DEC 
VAX 11/780 computer. Hard-copy reports were generated 
on a Tektronics 4207 graphics terminal. Stenosis severity 
was measured as percent diameter stenosis. Lesions 2::50% 
were considered significant. 
Thallium studies. Stress thallium studies were obtained 
in conjunction with treadmill exercise with use of a standard 
Bruce protocol. Exercise was continued until limited by 
symptoms (angina, shortness of breath, fatigue, leg pain), 
ischemic changes on the electrocardiogram (ECG) (> I mm 
ST segment depression) or until >85% of maximal predicted 
heart rate was reached. Approximately I min before cessa-
tion of exercise, 3 mCi of thallium-201 was injected intrave-
nously. Patients were continuously monitored for changes in 
blood pressure, heart rate and ECG until pre-exercise values 
returned. SPECT images were obtained with a General 
Electric 400 AC/Starcam camera. A total of 32 acquisitions 
were obtained at 40 s, each over 180°, with use of a 64 x 64 
matrix. Images were processed with a Hanning filter with a 
cutoff frequency of 0.83 Hz and a multipurpose collimator. 
Standard backprojection techniques were used to obtain the 
transaxial tomograms. Images were then reoriented in short-
axis and vertical and horizontal long-axis views. Redistribu-
tion images were obtained 4 h later with use of the same 
imaging procedure. 
Preparation of Tc-99m teboroxime. Teboroxime was pre-
pared within 4 h of patient administration. The lyophilized 
product was reconstituted with 0.5 to 1.0 ml of sterile 
pyrogen-free Tc-99m generator eluate, which did not contain 
> 100 mCi of Tc-99m pertechnetate as indicated in the 
manufacturer's protocol (Squibb Diagnostics). The solution 
was then heated in a water bath for 15 min at 100°C. The 
mixture was then cooled to room temperature and kept in a 
glass vial until ready for injection. 
The percent of Tc-99m pertechnetate and reduced hydro-
lyzed Tc-99m was determined by paper chromatography 
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Figure 1. • Regions of interest for perfusion interpretation are shown 
with the corresponding arterial distributions. Assignment of the 
posterior circulation and apex was verified by review of the coro-
nary angiograms. Regional assessment of perfusion was based on 
multiple slices. Bullseye reorientation was not performed. LAD = 
left anterior descending artery; LCx = left circumflex artery; 
RCA = right coronary artery. 
immediately after drug preparation. All preparations con-
tained <10% Tc-99m pertechnetate. 
Teboroxime imaging protocol. The same exercise proto-
col used for the thallium stress studies was used for teborox-
ime imaging. However, exercise was not continued for 1 min 
after administration of tracer as with thallium; instead, it was 
stopped immediately after Tc-99m teboroxime injection and 
SPECT imaging was begun within 2 min. The average dose 
of Tc-99m teboroxime was 25.2 ± 1 mCi. Teboroxime 
SPECT imaging was also performed with use of a GE 400 
AC/Starcam camera at 15 s per 6° arc over 180°. Images were 
reoriented in a manner similar to that of thallium studies with 
use of a Hanning filter with a 0.83 Hz cutoff and multipur-
pose collimator. Acquisitions required 10 min to complete. 
In two subjects, imaging was performed for 5 s per view. The 
shorter acquisition time produced images that were judged to 
be adequate for interpretation but of lesser quality than the 
15 s acquisitions. Rest images were obtained approximately 
1 h later, at the same dose used for the stress study. 
SPECT image interpretation. Two experienced observers 
(R.G., H.T.) interpreted the perfusion images without 
knowledge of the clinical and angiographic data. Images 
were randomly reviewed as stress and rest (redistribution) 
pairs independently and at a different time from the interpre-
tation of the other tracer study. Readers did not know the 
results of the perfusion images previously evaluated. Re-
gional perfusion was scored on a continuous scale from 0 to 
5, where 0 was considered to be definitely normal and 5 a 
severe perfusion defect. The results from the two graders 
were averaged and used to determine the presence of dis-
ease. Values from 0 to 2 were classified as negative and 
values from 3 to 5 as positive for disease. Regions of interest 
were matched to the arterial supply (native or graft) as 
illustrated in Figure 1 and independently verified (R.F.). The 
apex was matched to the culprit artery. Interobserver vari-
ability, defined as the difference between observer perfusion 
scores for a region, was also determined. Agreement was 
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Table 2. Results of Exercise Testing in 30 Patients 
Maximal heart rate (beats/min) 
Rate-pressure product* 
Exercise ECG response 
Positive (%) 
Negative (%) 
Angina during exercise (%) 
Thallium-201 
132 ± 13 
22.523 ± 4,010 
13 (50) 
\3 (50) 
9 (30) 
Teboroxime 
\32 ± 15 
22,099 ± 4,513 
11 (42) 
15 (58) 
8 (31) 
*Maximal systolic blood pressure x maximal heart rate. Values are mean 
values ± SD. p = NS for all variables. 
complete if both observers graded a region identically; 
disagreement was complete if the scores differed by 5 points. 
Statistical methods. Chi-square analysis with correction 
for continuity was used to determine whether there was a 
statistically significant difference between tracers versus 
quantitative coronary arteriography. Differences between 
thallium and Tc-99m teboroxime exercise tests were evalu-
ated using a Student's t test for paired data. Values are 
expressed as mean values ± SD. 
Results 
Comparison of thallium and teboroxime imaging with 
quantitative coronary arteriography. Table 2 lists the results 
of the ECG and hemodynamic measurements obtained with 
the thallium and teboroxime exercise stress tests. There 
were no differences in the rate-pressure product achieved, 
presence of angina or development of significant ST segment 
abnormalities. All patients exercised to a symptom-limited 
or target heart rate end point. 
The results of coronary arteriography and perfusion 
imaging in each patient are listed in Table 3 .. The preva-
lence of disease in the 25 patients with arteriography was 
68%. Ten patients had angiographic evidence of significant 
one vessel disease, six patients of two vessel disease and one 
patient of three vessel disease. Eight patients had no signif-
icant coronary disease. There were no differences between 
the two tracers versus arteriography for specific arterial 
distributions (Table 4). Results of imaging were abnormal in 
9 of the 10 patients with one vessel disease who underwent 
teboroxime imaging and in 8 of the 10 with thallium imaging 
(p = NS). In every case where two or three vessel disease 
was present by arteriography, thallium and Tc-99m teborox-
ime images were abnormal. In patients without arterio-
graphic evidence of disease, six of eight Tc-99m teboroxime 
studies were interpreted as normal versus three of five 
thallium studies (p = NS). When overall presence of disease 
was evaluated, there was no significant difference between 
arteriography and Tc-99m teboroxime or thallium imaging. 
With Tc-99m teboroxime imaging, 6 patients had reversible 
defects (19 segments) and 17 had fixed defects (39 segments). 
Similarly, with thallium imaging, reversible defects were 
present in 9 patients (31 segments) and fixed defects in 10 
patients (23 segments). 
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Table 3. Comparison of Anatomic Measures of Coronary Stenosis Severity With Perfusion Imaging in 30 Patients 
Pt. 
RCA LAD LCx 
No. %D TI-201 Tebo %0 TI-201 Tebo %0 TI-201 Tebo 
4 0 6 2 4 16 0 2 
2 56 4 5 82 5 4 2 0 
3 48 4 52 5 4 35 2 4 
4 64 0 0 45 0 I 29 0 2 
5 100 4 4 58 0 100 4 4 
6 99 5 4 19 0 11 0 0 
7 41 4 5 64 4 36 0 3 
8 38 2 0 51 0 3 42 0 2 
9 4 0 0 6 4 1 16 2 1 
10 0 0 0 100 5 4 46 3 1 
II 47 4 0 79 4 45 2 0 
12 43 0 0 18 0 0 7 0 0 
13 13 5 2 47 1 18 0 2 
14 16 0 4 48 0 0 11 0 0 
15 25 0 0 100 5 5 39 1 0 
16 100 5 3 36 0 2 63 4 0 
17 2 4 5 3 2 
18 59 4 4 68 0 0 43 2 0 
19 2 0 0 0 
20 100 5 4 12 2 2 65 0 
21 59 5 4 100 2 37 0 4 
22 9 0 4 2 15 2 
23 34 0 38 2 10 2 
24 0 0 2 4 0 0 
25 4 4 2 5 0 4 
26 I 2 2 0 0 
27 22 1 36 I 9 0 
28 37 5 99 5 99 5 
29 46 4 0 71 5 5 37 0 4 
30 40 4 4 72 5 5 21 
Perfusion images were evaluated with a scale from 0 to 5 with ~3 defined as ischemia. Values presented from perfusion images represent the highest mean 
score during stress within the arterial distribution. LCx = left circumflex artery; %0 = percent diameter stenosis; Tebo = teboroxime; Tl-201 = thallium-20I; 
- = no available data/not done. Other abbreviations as in Table 1. 
Two patients had false positive and two had false negative 
thallium studies. Two patients had a false positive and one 
patient had a false negative Tc-99m teboroxime study. One 
with a false positive teboroxime study who had a history of 
an inferior myocardial infarction had undergone angioplasty 
of the right coronary artery, which left a residual stenosis of 
16%. Teboroxime images showed an inferoposterior defect 
that, although consistent with the old myocardial infarction, 
was classified as a false positive result because of arterio-
graphic findings. The thallium images of this patient were 
interpreted as normal and thus considered to be a true 
negative result. This case illustrates the difficulty in compar-
ing anatomy with perfusion, particularly in patients with 
prior infarction. There was no apparent reason for the other 
false positive finding or the false negative result. 
On a regional basis, there were many false positive results 
for both Tc-99m teboroxime and thallium in the right coro-
nary artery distribution (Table 4). Although false positive 
thallium defects are common because of attenuation from 
overlying diaphragm, these results suggest that a similar 
problem may be present for Tc-99m teboroxime despite the 
higher photon energy of Tc-99m. 
Direct comparison of thallium and teboroxime perfusion. 
Thallium and teboroxime perfusion studies were in agree-
ment for the presence or absence of disease in 65% of 
posterolateral. 77% of anterior or septal (or both) and 85% of 
inferoposterior segments. Interpretation of Tc-99m teborox-
ime perfusion regions agreed with arteriographic data on the 
presence or absence of disease in 57 (76%) of 75 segments, 
and thallium studies were concordant in 46 (73%) of 63 
segments (p = NS). The overall concordance between 
thallium and teboroxime studies for the presence or absence 
of disease was 77%. 
Interobserver agreement for stress and rest images ob-
tained with thallium and Tc-99m teboroxime are summarized 
in Figure 2. In the stress images, there was absolute agree-
ment in 131 of 208 thallium studies and 133 of 240 Tc-99m 
teboroxime studies (p = NS). Similar results were obtained 
with redistribution thallium images (126 of 208) and rest 
Tc-99m teboroxime images (138 of 240). 
lACC Vol. 17, No.6 
May 1991:1297-302 
Table 4. Sensitivity and Specificity of Thallium and Teboroxime 
Imaging When Compared With Automated Quantitative 
Coronary Arteriography 
Thallium Teboroxime 
Overall disease presence 
QCA QCA 
+ + 
Tl+ 14 2 Tebo + 16 2 
Tl- 2 Tebo - 6 
Specific arterial distributions 
RCA RCA 
+ + 
TI + 7 6 Tebo + 7 
Tl- 7 Tebo - 12 
LAD LAD 
+ + 
Tl+ 9 Tebo + 9 
Tl- 3 8 Tebo - 4 II 
LCx LCx 
+ + 
Tl+ 2 2 Tebo + 2 4 
Tl- 16 Tebo - 2 17 
QCA = quantitative coronary arteriography; Tebo - and Tebo + = 
disease absent or present by teboroxime imaging; TI - and TI + = disease 
absent or present by thallium; other abbreviations as in Tables I and 3. 
Discussion 
Thallium versus teboroxime for perfusion imaging. The 
ideal tracer for perfusion imaging would be 100% extracted 
on first pass at all flow rates and retained in the myocardium 
for a long enough period to allow collection of accurate 
statistical information. It would also have a short physical or 
biologic half-life, or both, so that rest and stress studies 
could be performed in rapid succession. At present, the only 
single photon tracer available for perfusion imaging is thal-
lium-201. Thallium-201 has diffusion-limited extraction, a 
long half-life and low photon energy. In contrast, Tc-99m 
teboroxime has a high first-pass extraction, rapid clearance 
and the higher energy and shorter half-life of technetium-
99m. These characteristics would be expected to improve 
sensitivity. However, Stewart et al. (6) demonstrated in dogs 
that the rate of washout is directly proportional to flow. 
Therefore, one concern about Tc-99m teboroxime is whether 
this rapid clearance of activity would allow diagnostic stud-
ies using standard single head, rotating SPECT cameras. 
One might expect that early images would show greater 
differences in activity between high and low flow regions 
than would later acquisitions. These changes might degrade 
the regional information obtained during reconstruction and 
increase the number of false negative studies. Another 
potential problem with Tc-99m teboroxime is that scatter 
from the liver could increase apparent inferior wall activity 
and increase the number of false negative studies. 
The results of the current study suggest that Tc-99m 
teboroxime SPEeT imaging is comparable diagnostically to 
thallium tomographic imaging for assessment of coronary 
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Figure 2. Interobserver variability for stress (A) and redistribution/ 
rest (B). Perfusion defects were graded on a scale from 0 (normal) to 
5 (severe defect}. The abscissa is the absolute difference between 
segments scored by the two readers and the ordinate is the percent 
of segments for each difference in interpretation. TEBO = teborox-
ime. 
artery disease. There was no difference between the tracers 
on determination of disease in a given arterial distribution. In 
particular, there was no difference between the tracers for 
assessment of inferior wall perfusion. Interobserver variabil-
ity for stress and rest/redistribution studies was similar for 
both tracers and these values were similar to values obtained 
by others (13) for thallium. 
Considerations for Tc-99m teboroxime imaging. To mini-
mize the contribution of liver activity and optimize myocar-
dial counts, image acquisition was started within 2 min of 
Tc-99m teboroxime injection. The transfer of the patient 
from the treadmill to the SPECT camera was rehearsed 
before stress so that proper alignment could be achieved 
quickly. Unlike the procedure in thallium studies, the tracer 
was injected at peak exercise and the treadmill was then 
stopped. A possible alternative is use of pharmacologic 
stress with intravenous dipyridamole or adenosine. 
Teboroxime stress and rest image acquisitions were each 
completed in approximately 10 min. The entire study re-
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quired 90 min to 2 h (total setup and processing time). The 
shorter time necessary for Tc-99m teboroxime imaging 
should increase the daiiy number of procedures that can be 
performed by a camera and be more convenient for the 
patient. 
Study limitations. In this study, acquisitions were per-
formed using a "stop and shoot" approach, with each 15 s 
image followed by a 2 to 3 s dead time loss for the camera 
head to be repositioned. This resulted in a 10% to 15% loss 
of available activity. Image content would be expected to 
improve with continuous acquisition programs available on 
some instruments. 
In addition. no attempt was made to correct images for 
clearance of the tracer. The use of a multihead SPECT unit 
that is capable of rapid sequential scans should allow wash-
out information to be incorporated into the images and may 
improve sensitivity and specificity. 
We thank Jeannie Bobino and Grace Guerrero for their assistance with the 
preparation of the manuscript. 
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